SecBot SecBot
Insider Cluster (4 insiders) ·Filed Jul 30, 2026

ATRC

AtriCure, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago
Insider cluster: 3 insiders, $1.4M total
Actionable Insight • Neutral

The insider selling is minimal and likely reflects routine diversification after the stock's post-earnings run. No immediate bearish read-through; monitor for any acceleration in selling volume or a shift to C-suite open-market sales.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$37.76
T+0 close · Jul 30, 2026 · via day close
Latest settled
+61.76%
T+60 · $61.08
Vs SPY
+59.30%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 31 $37.76entry
  2. T+1 · 4mo ago +2.54%α +1.12% · $38.72
  3. T+5 · 3mo ago +9.61%α +6.10% · $41.39
  4. T+20 · 3mo ago +28.55%α +25.56% · $48.54
  5. T+60 · 22d ago +61.76%α +59.30% · $61.08
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three AtriCure insiders sold a total of $1.42M in open-market shares over the past week, representing just 0.075% of the $1.9B market cap. The sales follow the company's strong Q2 2026 earnings beat and raised guidance reported 11 days ago. The small size relative to market cap suggests routine profit-taking rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$1.4M
Insiders
4

Key Facts

  • Director Sven Wehrwein sold 25,000 shares at $37.84 for $946K on 2026-07-28.
  • Chief Mktg & Strategy Officer Justin Noznesky sold 6,182 shares at $38.80 for $240K on 2026-07-29.
  • Chief Scientific Officer Vinayak Doraiswamy sold 6,000 shares at $38.88 for $233K on 2026-07-28.
  • CEO Michael Carrel made non-cash gifts of 4,700 shares on 2026-07-30 (no economic impact).
  • Total open-market sales of $1.42M equal 0.075% of ATRC's $1.9B market cap, well below the 0.1% materiality threshold.
  • The cluster occurred within 11 days of a Q2 2026 earnings beat ($0.18 EPS vs $0.03 consensus) and raised guidance.

Financial Impact

Open-market insider sales of $1.42M, representing 0.075% of market cap, trivial relative to company size.

insider sellingmarket cap

Risk Factors

  • Insider selling could increase if the stock continues to rise, potentially signaling a top.
  • Future larger sales by C-suite executives would carry more weight and warrant a bearish reassessment.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
81% bullish (16 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ATRC-1785758471480

US Market Status

Market Closed · Opens in 7h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 3, 2026